| Evaluation of an Influenza Vaccination Implementation Strategy for Hospital Health Care Workers (NCT01481467) | University Medical Center Groningen | 2009-04-01 |
| Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults (NCT00868218) | Rebecca Cox | 2009-03-01 |
| Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use) (NCT01554826) | Hualan Biological Engineering, Inc. | 2009-03-01 |
| Evaluating Modes of Influenza Transmission Between Humans (NCT01150149) | University of Nottingham | 2009-03-01 |
| TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients (NCT00867139) | Fred Hutchinson Cancer Center | 2009-03-01 |
| Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years (NCT00825162) | Seqirus | 2009-03-01 |
| Vitamin A and Maternal-infant Flu Vaccine Response (NCT00817661) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2009-02-01 |
| Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B (NCT00828100) | Nanogen, Inc. | 2009-02-01 |
| Study to Evaluate Impact of School-based Influenza Vaccination on School Populations (NCT00844051) | Children's Hospital Los Angeles | 2009-01-01 |
| Rapid Flu Tests in Travelers With Fever (NCT00821626) | University of Lausanne Hospitals | 2009-01-01 |
| Heterosubtypic Immune Responses to Influenza in Older People (NCT00798343) | University Hospitals, Leicester | 2009-01-01 |
| Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza (NCT00833885) | Robert Koch Institut | 2009-01-01 |
| Influenza Resistance Information Study (NCT00884117) | Hoffmann-La Roche | 2009-01-01 |
| Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (NCT00800605) | Alachua Government Services, Inc. | 2008-12-01 |
| Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home (NCT00812110) | Akron Children's Hospital | 2008-12-01 |
| Study to Evaluate Nosocomial Transmission of Influenza (NCT00798421) | University Hospitals, Leicester | 2008-12-01 |
| A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine. (NCT00812981) | GlaxoSmithKline | 2008-11-15 |
| Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control (NCT00778895) | GlaxoSmithKline | 2008-11-10 |
| Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old) (NCT00812019) | Seqirus | 2008-11-01 |
| Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04 (NCT00814385) | University Hospitals, Leicester | 2008-11-01 |
| Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age (NCT03020472) | Stanford University | 2008-11-01 |
| Zanamivir Versus Trivalent Split Virus Influenza Vaccine (NCT00784784) | Mount Sinai Hospital, Canada | 2008-11-01 |
| H5N1 (Clade 2) Vaccination of Adults and Elderly (NCT00680069) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older (NCT00782431) | Alachua Government Services, Inc. | 2008-11-01 |
| Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem (NCT00758212) | Hadassah Medical Organization | 2008-11-01 |
| Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older (NCT00765076) | GlaxoSmithKline | 2008-10-16 |
| Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly (NCT00772889) | GlaxoSmithKline | 2008-10-09 |
| Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older (NCT00760617) | GlaxoSmithKline | 2008-10-06 |
| Influenza Vaccine Revaccination in Ambulatory Elderly Subjects (NCT00775450) | Sanofi Pasteur, a Sanofi Company | 2008-10-01 |
| Influenza Vaccine in HIV (NCT00764998) | Ottawa Hospital Research Institute | 2008-10-01 |
| Randomized Control Trial to Study the Efficacy of the Surgical Mask Versus the N95 Respirator to Prevent Influenza (NCT00756574) | McMaster University | 2008-10-01 |
| Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children (NCT00764790) | GlaxoSmithKline | 2008-10-01 |
| Evaluation of a School-based Influenza Vaccination Program (NCT00961337) | Centers for Disease Control, Taiwan | 2008-10-01 |
| A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine (NCT00735475) | Seqirus | 2008-10-01 |
| A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age (NCT00848887) | Novartis | 2008-10-01 |
| Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older (NCT00848848) | Seqirus | 2008-10-01 |
| Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults (NCT00772109) | Sanofi Pasteur, a Sanofi Company | 2008-10-01 |
| Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older (NCT00753272) | GlaxoSmithKline | 2008-09-15 |
| Evaluate the Safety and Immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Healthy Adults (NCT00754455) | Novavax | 2008-09-01 |
| Hutterite Influenza Prevention Study (NCT00877396) | McMaster University | 2008-09-01 |
| Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone® (NCT00755274) | Sanofi Pasteur, a Sanofi Company | 2008-09-01 |
| H5N1 Priming and Boosting Strategies (NCT00703053) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-09-01 |
| Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine (NCT00734175) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-09-01 |
| Immunogenicity and Safety of GSK Biologicals' FluLaval® TF (NCT00727428) | GlaxoSmithKline | 2008-08-05 |
| A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination (NCT00743275) | Sanofi Pasteur, a Sanofi Company | 2008-08-01 |
| A Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults (NCT00942071) | University of Oxford | 2008-08-01 |
| Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups (NCT00711295) | Alachua Government Services, Inc. | 2008-08-01 |
| Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults (NCT00741806) | AVIR Green Hills Biotechnology AG | 2008-08-01 |
| Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years (NCT00719043) | GlaxoSmithKline | 2008-07-11 |
| A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults (NCT00706563) | GlaxoSmithKline | 2008-07-07 |
| Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine (NCT00730457) | VaxInnate Corporation | 2008-07-01 |
| A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere (NCT01303510) | Crucell Holland BV | 2008-07-01 |
| Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects (NCT00748150) | Novartis Vaccines | 2008-07-01 |
| A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64 (NCT00695669) | GlaxoSmithKline | 2008-06-05 |
| Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix (NCT00693706) | GlaxoSmithKline | 2008-06-02 |
| Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season. (NCT00665509) | Solvay Biologicals | 2008-06-01 |
| A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine (NCT00677820) | MedImmune LLC | 2008-06-01 |
| A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza (NCT00706732) | AlphaVax, Inc. | 2008-06-01 |
| Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines (NCT00735020) | Novartis Vaccines | 2008-06-01 |
| Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation (NCT00718146) | Sanofi Pasteur, a Sanofi Company | 2008-06-01 |
| Oseltamivir Randomised Controlled Efficacy Trial (NCT00707941) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2008-05-01 |
| Household Influenza Transmission Study (NCT01251679) | Centers for Disease Control and Prevention | 2008-04-09 |
| Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine (NCT00664417) | Sanofi | 2008-04-01 |
| Efficacy of Influenza Vaccine in HIV Infected Adults (NCT00757900) | University of Witwatersrand, South Africa | 2008-04-01 |
| CS-8958 Single Inhaled Dose in Elderly (NCT00657111) | Biota Scientific Management Pty Ltd | 2008-04-01 |
| Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study (NCT00646152) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-03-24 |
| Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules (NCT00652743) | GlaxoSmithKline | 2008-03-23 |
| Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations (NCT00633074) | GlaxoSmithKline | 2008-03-03 |
| A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults (NCT00562484) | Seqirus | 2008-03-01 |
| Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults (NCT00546585) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-03-01 |
| Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age (NCT00593502) | Hospital District of Southwestern Finland | 2008-02-01 |
| FLU A+B Nasal Swab Clinical Study (NCT00636662) | Response Biomedical Corp. | 2008-02-01 |
| Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years (NCT00616928) | GlaxoSmithKline | 2008-01-23 |
| Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza (NCT00610935) | BioCryst Pharmaceuticals | 2008-01-01 |
| Efficacy Study of Early Versus Late Oseltamivir Administration for Treating and Preventing Influenza (NCT00555893) | Marshfield Clinic Research Foundation | 2008-01-01 |
| Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults (NCT00623181) | Sanofi Pasteur, a Sanofi Company | 2008-01-01 |
| Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months (NCT00649883) | Novartis | 2008-01-01 |
| Influenza Challenge Study in Healthy Volunteers (NCT02746211) | Hvivo | 2008-01-01 |
| Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old (NCT00617851) | Novartis Vaccines | 2007-11-01 |
| Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects (NCT00606359) | Sanofi Pasteur, a Sanofi Company | 2007-11-01 |
| Influenza Vaccination in the Emergency Department (NCT00822627) | University of Arizona | 2007-11-01 |
| Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII) (NCT00566345) | Alachua Government Services, Inc. | 2007-11-01 |
| Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above (NCT00620815) | Novartis Vaccines | 2007-11-01 |
| Immunogenicity and Tolerability Study of FluvalAB FL-K-004 Trivalent Influenza Vaccine (NCT00778297) | Fluart Innovative Vaccine Ltd, Hungary | 2007-11-01 |
| Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults (NCT00538473) | GlaxoSmithKline | 2007-10-23 |
| Revaccination With Influenza Vaccine GSK1247446A (NCT00545025) | GlaxoSmithKline | 2007-10-15 |
| Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults (NCT00529516) | GlaxoSmithKline | 2007-10-15 |
| Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults (NCT00538213) | GlaxoSmithKline | 2007-10-15 |
| Study to Evaluate an Influenza Vaccine Candidate (NCT00540228) | GlaxoSmithKline | 2007-10-05 |
| Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup (NCT00579345) | Novartis | 2007-10-01 |
| Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents (NCT00645411) | Novartis | 2007-10-01 |
| Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects (NCT00630331) | Novartis Vaccines | 2007-10-01 |
| Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine (NCT00561002) | Sanofi Pasteur, a Sanofi Company | 2007-10-01 |
| Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects (NCT00551031) | Sanofi | 2007-10-01 |
| Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults (NCT00545701) | Sanofi Pasteur, a Sanofi Company | 2007-10-01 |
| Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017) (NCT01827462) | Stanford University | 2007-10-01 |
| Feasibility of Cocooning Immunization Strategy With Influenza Vaccine (NCT00570037) | Duke University | 2007-10-01 |
| Single Dose Escalating Study of DAS181 in Adults (NCT00527865) | Ansun Biopharma, Inc. | 2007-10-01 |
| Testing a Personally Controlled Health Record to Ameliorate Influenza at MIT (NCT00531700) | Boston Children's Hospital | 2007-10-01 |
| Influenza Vaccine in Premature Infants (NCT00455169) | University of Rochester | 2007-10-01 |